Oracle has shed over 32% YTD and nearly 40% from its peak, with the selloff overwhelmingly driven by capex shock and FCF concerns rather than deteriorating revenue fundamentals — FY2026 delivered 17% revenue growth, 37% net income expansion, and a $638B RPO backlog that dwarfs current annual run-rate. At $131.54, the stock trades at a deeply compressed multiple relative to its growth profile, and the designation as a critical financial infrastructure provider in the UK [N1] alongside Crusoe's $30B valuation raise validating Oracle's AI data center ecosystem [N7] suggest the market is mispricing the long-term platform value. With institutional selling appearing exhausted after five consecutive deteriorating intervals and geopolitical risk [N10] creating broad equity weakness that indiscriminately punishes quality names, a contrarian entry at current levels offers asymmetric upside toward a fundamental re-rating as Q1 FY2027 results approach.